Extalvo is developing a precision drug platform that enables clinicians to safely and precisely taper patients off medications that cause physical dependence, closing a treatment gap that no currently approved product addresses.
Precision.
Recovery.
Hope.
About Extalvo
Extalvo is a biotechnology company focused on improving how patients discontinue long-term medications. We believe medication tapering should be as precise and evidence-based as the therapies themselves.
Our platform pairs precision liquid formulations of FDA-approved medications with a precision delivery platform and connected protocol tools, so clinicians can build each taper around the patient rather than around the tablet.
By addressing one of healthcare's most overlooked challenges, we aim to improve safety, increase adherence, and help patients regain independence with confidence.
One tapering platform whose formulation, precision liquid formulations and connected tools are engineered to work together, each around the same goal: dose control precise enough to individualize a taper.
Precision Formulation
Precision liquid formulations of FDA-approved medications, concentration-laddered to reach the sub-milligram dose steps a taper requires and tablets cannot deliver.
Precision Delivery
A precision liquid platform that turns those formulations into exact, repeatable doses, so each reduction is controlled by the platform, not by patient technique.
Connected Support
Connected tools, in development, to support tapering protocols, adherence, and clinician oversight across the full course of therapy.
Our Platform
Our Vision
We envision a future where every patient has access to safe, personalized medication tapering supported by evidence-based technologies that improve outcomes and restore independence.
Why Extalvo
Precision
Individualized tapering technologies designed for sub-milligram accuracy.
Clinician Focused
Designed to integrate seamlessly into real-world clinical practice and workflows.
Broad Impact
Addressing an urgent unmet need affecting millions of patients worldwide.
